Reminyl 4 mg Tablet, single dose
Sponsors
Actavis Inc.
Conditions
Healthy
Phase 1
Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fed Conditions
CompletedNCT01190761
Start: 2004-12-31End: 2004-12-31Updated: 2010-08-30
Bioequivalence Study of Galantamine 4 mg Tablet and Reminyl Following a 4 mg Dose in Healthy Subjects Under Fasting Conditions
CompletedNCT01190748
Start: 2004-11-30End: 2004-12-31Updated: 2024-02-22